Rebuttal to Deacon and Holst: “Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1” versus “Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective”

By Demuth H-U.   Hinke S.A.   Pederson R.A.   McIntosh C.H.S.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 2, 2002-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes

By  

Current Enzyme Inhibition, Vol. 1, Iss. 1, 2005-01 ,pp. : 65-73

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes

By  

Current Enzyme Inhibition, Vol. 7, Iss. 4, 2011-12 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Interaction Between Enzyme Diabetes Type 2 Dipeptidyl- Peptidase (DPP-4) and Main Compound of Cinnamon

By  

Current Enzyme Inhibition, Vol. 14, Iss. 1, 2018-03 ,pp. : 61-66

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine

By Al-masri Ihab M.   Mohammad Mohammad K.   Tahaa Mutasem O.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 5, 2009-10 ,pp. : 1061-1066

Informa Healthcare

Access to resources Recommend Favorite